Cargando…
Chronic hepatitis delta: A state-of-the-art review and new therapies
Chronic delta hepatitis is the most severe form of viral hepatitis affecting nearly 65 million people worldwide. Individuals with this devastating illness are at higher risk for developing cirrhosis and hepatocellular carcinoma. Delta virus is a defective RNA virus that requires hepatitis B surface...
Autores principales: | Gilman, Christy, Heller, Theo, Koh, Christopher |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718034/ https://www.ncbi.nlm.nih.gov/pubmed/31528088 http://dx.doi.org/10.3748/wjg.v25.i32.4580 |
Ejemplares similares
-
Pharmacokinetics and pharmacodynamics modeling of lonafarnib in patients with chronic hepatitis delta virus infection
por: Canini, Laetitia, et al.
Publicado: (2017) -
Distinct histological patterns in chronic hepatitis D with nucleos(t)ide analogue therapy
por: Hercun, Julian, et al.
Publicado: (2023) -
Therapeutic Strategies and New Intervention Points in Chronic Hepatitis Delta Virus Infection
por: Guo, Zhimin, et al.
Publicado: (2015) -
Developing New Therapies for Delta Hepatitis: The Race Is On
por: Gençdal, Genco, et al.
Publicado: (2021) -
Chronic urticaria in adults: state-of-the-art in the new
millennium()
por: Criado, Paulo Ricardo, et al.
Publicado: (2015)